» Authors » Paula van Dommelen

Paula van Dommelen

Explore the profile of Paula van Dommelen including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 100
Citations 1205
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Dimitri P, van Dommelen P, Banerjee I, Bellazzi R, Ciaccio M, De Arriba Munoz A, et al.
Front Endocrinol (Lausanne) . 2024 Oct; 15:1436778. PMID: 39473505
Smart technologies and connected health are providing opportunities for improved healthcare for chronic conditions. Acceptance by healthcare professionals (HCPs) and patients is crucial for successful implementation. Evidence-based standards, technological infrastructure...
2.
de Arriba A, van Dommelen P, Savage M
Front Endocrinol (Lausanne) . 2024 Oct; 15:1450573. PMID: 39429736
Introduction: Human growth hormone (hGH) therapy in children can be administered by subcutaneous injection using either a manual non-connected device, which is a portable injection pen loaded with a pre-filled...
3.
van Dommelen P
Acta Paediatr . 2024 Oct; 114(1):12-13. PMID: 39387138
No abstract available.
4.
van Dommelen P, Rivera-Romero O, Arnaud L, Zucchiatti C, Koledova E
Stud Health Technol Inform . 2024 Aug; 316:38-42. PMID: 39176668
Adherence to recombinant human growth hormone (r-hGH; somatropin, [Saizen®], Merck Healthcare KGaA, Darmstadt, Germany) treatment is important to achieve positive growth and other outcomes in children with growth disorders. Automated...
5.
Kleinhuis J, de Graaff-Korf K, van Straaten H, van Dommelen P, Benard M
PLoS One . 2024 Aug; 19(8):e0308470. PMID: 39093882
[This corrects the article DOI: 10.1371/journal.pone.0297363.].
6.
van Dommelen P, Arnaud L, Assefi A, Crespo M, Debicki M, Michelis F, et al.
Front Endocrinol (Lausanne) . 2024 Jul; 15:1372716. PMID: 39015178
Introduction: This study in Argentina evaluated the impact of the growzen™ buddy smartphone app on adherence to recombinant human growth hormone (r-hGH) treatment. Methods: The adherence data, invitation dates with...
7.
Thieren S, van Dommelen P, Benard M
Am J Audiol . 2024 May; 33(3):613-623. PMID: 38768075
Purpose: The aim of this study was to investigate the short- and long-term effects of a new cognitive sound exposure therapy (CSET) in patients with hyperacusis. Method: A new therapy...
8.
van Dommelen P, van Dijk O, de Wilde J, Verkerk P
Orphanet J Rare Dis . 2024 May; 19(1):192. PMID: 38730494
Background: In patients without a family history, Duchenne muscular dystrophy (DMD) is typically diagnosed at around 4-5 years of age. It is important to diagnose DMD during infancy or toddler...
9.
van Dommelen P, Schat-Savy C, Huizing A, Detmar S, Bakker L, Verkerk P
Ann Hum Biol . 2024 May; 51(1):2342529. PMID: 38700227
Background: The charity foundation Association Soutien Enfants Togo started a child health care (CHC) centre in Togo that was modelled after the Dutch high-quality CHC system to improve child health....
10.
Kleinhuis J, de Graaff-Korf K, van Straaten H, van Dommelen P, Benard M
PLoS One . 2024 Feb; 19(2):e0297363. PMID: 38416728
Objective: The aim of this study is to assess the neonatal click Auditory Brainstem Response (ABR) results in relation to the subsequently determined mean hearing loss (HL) over 1, 2...